Shopping Cart
Remove All
Your shopping cart is currently empty
Cofetuzumab (PF-06523435) is a monoclonal antibody targeting protein tyrosine kinase 7 (PTK7). It can be used to synthesize the ADC compound cofetuzumab pelidotin.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | - | In Stock | |
| 5 mg | $745 | - | In Stock | |
| 10 mg | $1,180 | - | In Stock | |
| 25 mg | $1,870 | - | In Stock | |
| 50 mg | $2,520 | - | In Stock |
| Description | Cofetuzumab (PF-06523435) is a monoclonal antibody targeting protein tyrosine kinase 7 (PTK7). It can be used to synthesize the ADC compound cofetuzumab pelidotin. |
| In vitro | Cofetuzumab (PF-06523435) is a humanized IGG1-κmonoclonal antibody targeting PTK7. |
| Synonyms | PF-06523435, PF06523435, hu24 |
| Reactivity | Human |
| Verified Activity | Immobilized Human PTK7/CCK4 Protein (Fc) at 2 μg/mL (30 μL/well) can bind Cofetuzumab. The EC50 is 0.08093 μg/mL. |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | PTK7/CCK4 |
| Molecular Weight | 146.7 kDa |
| Cas No. | 1869928-62-0 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.